Feature Channels: Liver Disease

Filters close
Newswise: Liver cancer treatment costly for Medicare patients, UT Southwestern study finds
Released: 30-Jan-2023 4:25 PM EST
Liver cancer treatment costly for Medicare patients, UT Southwestern study finds
UT Southwestern Medical Center

Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.

Released: 30-Jan-2023 2:00 PM EST
AASLD Announces Dr. Joseph K. Lim as New Editor-in-Chief of Clinical Liver Disease
American Association for the Study of Liver Diseases (AASLD)

The American Association for the Study of Liver Diseases (AASLD) is pleased to announce that Dr. Joseph K. Lim, MD, FAASLD of Yale University will serve as the next Editor-in-Chief of Clinical Liver Disease (CLD), a free multimedia review journal that aims to provide education for clinicians diagnosing and managing patients with liver disease.

Released: 27-Jan-2023 1:15 PM EST
Tool to predict the impact of diets on cancerous & healthy cells
Francis Crick Institute

Researchers at the Francis Crick Institute and King’s College London have created a tool to predict the effects of different diets on both cancerous cells and healthy cells.

Released: 27-Jan-2023 11:30 AM EST
AASLD Hepatology Award with Harold Amos Medical Faculty Development Program
American Association for the Study of Liver Diseases (AASLD)

In support of our unwavering commitment to champion diversity, equity and inclusion in the field of hepatology, AASLD is pleased to announce the development of our own hepatology award.

24-Jan-2023 4:15 PM EST
Ignoring Native American data perpetuates misleading white ‘deaths of despair’ narrative
University of California, Los Angeles (UCLA), Health Sciences

An increase in "deaths of despair" in recent decades has been frequently portrayed as a phenomenon affecting white communities, but a new analysis in The Lancet shows the toll has been greater on Native Americans.

Released: 18-Jan-2023 9:35 AM EST
Liver Associations Join Forces for Groundbreaking Viral Hepatitis Summit
American Association for the Study of Liver Diseases (AASLD)

Join the greatest minds in hepatology across the continent for a game-changing two-day event, the 2023 North American Viral Hepatitis Elimination Summit, on March 24-25 in Los Angeles.

Released: 17-Jan-2023 11:30 AM EST
Researchers Identify How HIV/Hepatitis Drug Harms the Kidneys
American Physiological Society (APS)

A first-of-its-kind study identifies mechanisms that explain how a drug commonly used to treat HIV and hepatitis causes kidney disease and kidney injury. The study is published ahead of print in Function.

Not for public release

This news release is embargoed until 16-Jan-2023 5:00 PM EST Released to reporters: 10-Jan-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 16-Jan-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children
Released: 16-Jan-2023 4:00 PM EST
New research identifies a potential treatment target for hepatoblastoma, the most common liver cancer in children
Elsevier

Although rare compared to adult liver cancers, hepatoblastoma is the most common pediatric liver malignancy, and its incidence is increasing.

Released: 12-Jan-2023 12:25 PM EST
Blood test shows common and dangerous pregnancy complications
Frontiers

Scientists at Ningbo University, China have identified biomarkers that could provide an early warning system for three common and dangerous pregnancy complications: pre-eclampsia, gestational diabetes, and a liver condition called intrahepatic cholestasis.

Released: 10-Jan-2023 5:10 PM EST
Unraveling key determinant of successful therapeutic vaccination against chronic hepatitis B
Elsevier

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments rarely succeed in curing the infection.

Newswise: Consumption of fast food linked to liver disease
Released: 10-Jan-2023 3:05 AM EST
Consumption of fast food linked to liver disease
Keck Medicine of USC

A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology found that eating fast food is associated with nonalcoholic fatty liver disease, a potentially life-threatening condition in which fat builds up in the liver.

Newswise: January Issue of AJG Includes Clinical Guidelines for Diagnosis and Management of Celiac Disease, Gastrointestinal Subepithelial Lesions
Released: 6-Jan-2023 9:00 AM EST
January Issue of AJG Includes Clinical Guidelines for Diagnosis and Management of Celiac Disease, Gastrointestinal Subepithelial Lesions
American College of Gastroenterology (ACG)

The January issue of AJG features two ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease (2013 update) and Diagnosis and Management of Gastrointestinal Subepithelial Lesions (new).

Released: 5-Jan-2023 2:55 PM EST
Improved diagnostic tools needed for chronic hepatitis B patients in Africa
University of Liverpool

A group of international researchers is calling for revised guidelines to help improve access to hepatitis B treatment in Africa.

Newswise: Cedars-Sinai Comprehensive Transplant Center Welcomes New Faculty
Released: 5-Jan-2023 10:05 AM EST
Cedars-Sinai Comprehensive Transplant Center Welcomes New Faculty
Cedars-Sinai

Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.

Newswise: Incurable liver disease may prove curable
Released: 4-Jan-2023 4:00 PM EST
Incurable liver disease may prove curable
Sanford Burnham Prebys

Research has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug. The study, published in the Proceedings of the National Academy of Sciences, has the potential to transform treatment for this rare disease and may also have implications for more common diseases.

Newswise: Potential New Targets Identified in Advanced Non-Alcoholic Fatty Liver Disease
3-Jan-2023 1:45 PM EST
Potential New Targets Identified in Advanced Non-Alcoholic Fatty Liver Disease
Mount Sinai Health System

Using the latest technologies—including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD). The research was led by investigators at the Icahn School of Medicine at Mount Sinai. Utilizing these innovative methods, the investigators discovered a network of cell-to-cell communication driving scarring as liver disease advances. The findings, published online on January 4 in Science Translational Medicine, could lead to new treatments.

Newswise: Hackensack Meridian Mountainside Medical Group welcomes Masood Rizvi, M.D., gastroenterologist
Released: 3-Jan-2023 11:45 AM EST
Hackensack Meridian Mountainside Medical Group welcomes Masood Rizvi, M.D., gastroenterologist
Hackensack Meridian Health

Mountainside Medical Group has announced that gastroenterologist Masood Rizvi, M.D., has joined the practice.

Newswise: December Research Highlights
Released: 29-Dec-2022 5:45 PM EST
December Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.



close
1.89331